Keros Therapeutics · 1 day ago
Senior Accountant
Lexington, MA (Hybrid)
Full-time
Hybrid
Mid, Senior Level
$94K/yr - $122K/yr
3+ years expKeros is focused on delivering significant clinical benefits through innovative product candidates targeting TGF-β signaling. They are seeking a Senior Accountant with clinical accounting experience to manage key elements of the monthly general ledger close and support the finance team in various accounting functions.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Perform assigned daily accounting transactions, and work with the accounting team members, to support departmental or corporate goals
Drive the clinical and R&D study reconciliations and variance analysis including, but not limited to, preparing monthly journal entries to ensure completeness and accuracy
Review contracts, set up and maintain CRO, CMO, or other R&D study workbooks
Interact and own cross-functional communication with internal clinical project managers, or external vendors to determine and prepare monthly accruals
Assist in maintaining strong internal controls and related documentation to comply with SOX 404
Assist with financial statement audits and quarterly reviews by providing requested supporting schedules and documents to auditors
Continuously support improvement of accounting processes to make work more efficiently
Perform other related duties and assist with special projects on an as needed basis
Qualification
Required
3+ years of progressive accounting experience within the life science industry required
Exposure to CRO, CMO, or other complex expense calculations required
Strong ERP system and Excel skills
Detail oriented, organized, and effective written and verbal communication required
CPA is required
Preferred
Bachelor's or master's degree in Accounting preferred
Public audit experience with a public life science company preferred
Exposure to SOX 404 preferred
Experience with General Ledger functions and the month end close processes preferred
Company
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
51-200 employees
H1B Sponsorship
Keros Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2022 (3)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$379.5MKey Investors
Pontifax
2024-01-03Post Ipo Equity· $140M
2020-11-13Post Ipo Equity· $149.5M
2020-04-07IPO
Leadership Team
Lorena Lerner
Chief Scientific Officer
Recent News
Keros Therapeutics, Inc.
2025-11-21
2025-11-20
Keros Therapeutics, Inc.
2025-11-19
Company data provided by crunchbase